Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Vimnerixin

Cat. No.: IBDI-431573

Vimnerixin (AZD4721) is the potent and orally active antagonist of acidic CXC chemokine receptor 2 (CXCR2). Vimnerixin has the potential for the research of inflammatory disease.

Size (Solid):

Product Details

Target CXCR
Molecular Weight 472.55
Appearance Solid
Synonyms AZD4721, RIST4721
SMILES O=S(NC1=NC(SCC2=CC=C(C=C2)F)=NC(O[[email protected]](C)[[email protected]@H](O)CO)=C1)(N3CC(C3)C)=O
Purity 99.39%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Powder: -20°C/3 years; 4°C/2 years
In solvent: -80°C/6 months; -20°C/1 month
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.